Study Reference No. - 20-336

Study Type Demographic Gender Age Location Compensation
Investigational Oral Medicated Healthy volunteers Males and Females 18 - 55 years old Saint Petersburg FL $1000
Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S Food and Drug Administration (FDA)] capsule is bioequivalent (to see if the active test medication is absorbed into the body at the same rate and amount as an already approved medication)] to a currently marketed capsule, as well as to monitor the safety of the study participants.

Study Duration

3 visits

Study Schedule

General Screening


Medical Screening

Jul 29, 2020 - Aug 02, 2020

Study Visit(s)

Cohort I, Period I: Wed, Aug 12, 2020 - Fri, Aug 14,2020
Cohort I, Period II: Mon, Aug 19, 2020 - Wed, Aug 21,2020

Cohort II, Period I: Fri, Aug 14, 2020 - Sun, Aug 16,2020
Cohort II, Period II: Wed, Aug 21, 2020 - Fri, Aug 23,2020

Follow-Up Visit(s)


Other Notes